FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386084167> ?p ?o ?g. }

• W4386084167 endingPage "7" @default.
• W4386084167 startingPage "1" @default.
• W4386084167 abstract "Emerging meta-analytical evidence indicates that baseline exposure to antipsychotics and to antidepressants in individuals at clinical high-risk for psychosis (CHR-P) have opposite prognostic effects as regards imminent transition to psychosis, with antipsychotics associated with higher risk and antidepressants associated with a lower risk in comparison to not-exposed individuals. Despite their common use, baseline exposure to benzodiazepines (BDZ) in CHR-P has surprisingly received poor attention as a potential risk modulator for transition to psychosis. The current systematic review and meta-analysis were performed to fix such a knowledge gap.Systematic scrutiny of Medline and Cochrane library, performed up to 31 December 2022, searching for English-language studies on CHR-P reporting numeric data about the sample, the transition outcome at a predefined follow-up time and raw data on BDZ baseline exposure in relation to such outcome.Of 1893 identified records, five studies were included in the systematic review and meta-analysis. The proportion of participants with exposure to BDZ at baseline ranged from 5.5% (one study) to 46.2%, with an average of 16.8%. At the end of the period of observation, i.e., the follow-up as reported in the study, 28.4% [95% confidence interval (CI) 19.7-39.1%] participants developed psychosis among the BDZ-exposed against 9.3% (7.3 to 11.9%) among the controls. CHR-P participants who were already under BDZ treatment at baseline had more than double chance of transition to psychosis than CHR-P participants who were BDZ-naïve. The risk ratio (RR) was 2.42 (95% CI 1.38-4.23) in the common effects model (z = 3.09; p = 0.002), and 2.40 (1.53 to 3.77) in the random-effects model (z = 5.40; p = 0.006; tau-squared = 0.0). There was no relevant heterogeneity: Cochran's Q = 1.49; df = 4; p = 0.828; I2 = 0.0% (95% CI 0.0-79%). Quality was good in four studies.Ongoing BDZ exposure at inception in CHR-P is associated with a higher risk of transition to psychosis at follow up. This meta-analytic association, which echoes a similar effect of baseline antipsychotic exposure, plausibly indicates that the clinicians' prescription of pharmacological intervention captures some form of prognostically-relevant information (e.g. an anxiety permeated mental state requiring BDZ prescription) that are not adequately encompassed by current CHR-P categorical criteria." @default.
• W4386084167 created "2023-08-24" @default.
• W4386084167 creator A5019574958 @default.
• W4386084167 creator A5058751277 @default.
• W4386084167 creator A5059180331 @default.
• W4386084167 date "2023-08-23" @default.
• W4386084167 modified "2023-09-26" @default.
• W4386084167 title "Baseline benzodiazepine exposure is associated with greater risk of transition in clinical high-risk for psychosis (CHR-P): a meta-analysis" @default.
• W4386084167 cites W1517271399 @default.
• W4386084167 cites W1784175517 @default.
• W4386084167 cites W1964435302 @default.
• W4386084167 cites W1964605289 @default.
• W4386084167 cites W1969060465 @default.
• W4386084167 cites W1995662581 @default.
• W4386084167 cites W2030223911 @default.
• W4386084167 cites W2035581455 @default.
• W4386084167 cites W2036756589 @default.
• W4386084167 cites W2090521204 @default.
• W4386084167 cites W2092923243 @default.
• W4386084167 cites W2104309828 @default.
• W4386084167 cites W2109887283 @default.
• W4386084167 cites W2117200377 @default.
• W4386084167 cites W2121457510 @default.
• W4386084167 cites W2139168999 @default.
• W4386084167 cites W2140606211 @default.
• W4386084167 cites W2147784939 @default.
• W4386084167 cites W2148361291 @default.
• W4386084167 cites W2156098321 @default.
• W4386084167 cites W2157823046 @default.
• W4386084167 cites W2194009663 @default.
• W4386084167 cites W2521776771 @default.
• W4386084167 cites W2567624324 @default.
• W4386084167 cites W2746334579 @default.
• W4386084167 cites W2930850699 @default.
• W4386084167 cites W2953951094 @default.
• W4386084167 cites W2991792334 @default.
• W4386084167 cites W2996371237 @default.
• W4386084167 cites W3016811923 @default.
• W4386084167 cites W3031969505 @default.
• W4386084167 cites W3041018691 @default.
• W4386084167 cites W3088790307 @default.
• W4386084167 cites W3089073957 @default.
• W4386084167 cites W3101231306 @default.
• W4386084167 cites W3158894358 @default.
• W4386084167 cites W3163461956 @default.
• W4386084167 cites W3182961820 @default.
• W4386084167 cites W3191832954 @default.
• W4386084167 cites W3209585723 @default.
• W4386084167 cites W4200535413 @default.
• W4386084167 cites W4251211582 @default.
• W4386084167 cites W4281658554 @default.
• W4386084167 cites W4296999561 @default.
• W4386084167 cites W4313023832 @default.
• W4386084167 cites W4362640197 @default.
• W4386084167 cites W4377246798 @default.
• W4386084167 doi "https://doi.org/10.1017/s0033291723002180" @default.
• W4386084167 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37609894" @default.
• W4386084167 hasPublicationYear "2023" @default.
• W4386084167 type Work @default.
• W4386084167 citedByCount "0" @default.
• W4386084167 crossrefType "journal-article" @default.
• W4386084167 hasAuthorship W4386084167A5019574958 @default.
• W4386084167 hasAuthorship W4386084167A5058751277 @default.
• W4386084167 hasAuthorship W4386084167A5059180331 @default.
• W4386084167 hasConcept C118552586 @default.
• W4386084167 hasConcept C126322002 @default.
• W4386084167 hasConcept C15744967 @default.
• W4386084167 hasConcept C17744445 @default.
• W4386084167 hasConcept C189708586 @default.
• W4386084167 hasConcept C199539241 @default.
• W4386084167 hasConcept C2776478404 @default.
• W4386084167 hasConcept C2779473830 @default.
• W4386084167 hasConcept C2779727114 @default.
• W4386084167 hasConcept C44249647 @default.
• W4386084167 hasConcept C70410870 @default.
• W4386084167 hasConcept C71924100 @default.
• W4386084167 hasConcept C82789193 @default.
• W4386084167 hasConcept C95190672 @default.
• W4386084167 hasConceptScore W4386084167C118552586 @default.
• W4386084167 hasConceptScore W4386084167C126322002 @default.
• W4386084167 hasConceptScore W4386084167C15744967 @default.
• W4386084167 hasConceptScore W4386084167C17744445 @default.
• W4386084167 hasConceptScore W4386084167C189708586 @default.
• W4386084167 hasConceptScore W4386084167C199539241 @default.
• W4386084167 hasConceptScore W4386084167C2776478404 @default.
• W4386084167 hasConceptScore W4386084167C2779473830 @default.
• W4386084167 hasConceptScore W4386084167C2779727114 @default.
• W4386084167 hasConceptScore W4386084167C44249647 @default.
• W4386084167 hasConceptScore W4386084167C70410870 @default.
• W4386084167 hasConceptScore W4386084167C71924100 @default.
• W4386084167 hasConceptScore W4386084167C82789193 @default.
• W4386084167 hasConceptScore W4386084167C95190672 @default.
• W4386084167 hasLocation W43860841671 @default.
• W4386084167 hasLocation W43860841672 @default.
• W4386084167 hasOpenAccess W4386084167 @default.
• W4386084167 hasPrimaryLocation W43860841671 @default.
• W4386084167 hasRelatedWork W1885119863 @default.
• W4386084167 hasRelatedWork W2015042281 @default.

• next